Krsnaa Diagnostics Limited — Investor Meet, 29-05-2026: Analysts/Institutional Investor Meet/Con. Call Updates

Krsnaa Diagnostics reported FY26 revenue of **772.8 Cr**, EBITDA of **214.9 Cr** (28% margin), and PAT of **101.4 Cr**. Q4 PAT grew 101% YoY to **41.7 Cr**. The retail business expanded sixfold to **60 Cr** (8% of FY26 revenue), targeting double-digit contribution in FY27. Rajasthan PPP is largely implemented, expecting **100-150 Cr** FY27 revenue, with full rollout by Q2 FY27 and ~10 MRI centers going live. **500 Cr** capex is planned for FY27 capitalization. DSO improved to 139 days (target sub-120). Management remains confident, focused on national healthcare infrastructure and sustaining margins.